A European Multicentre Drug Utilisation Study of the Impact of Regulatory Measures on Prescribing of Codeine for Pain in Children

Overview

Journal Pharmacoepidemiol Drug Saf

Publisher Wiley

Specialties Pharmacology
Public Health

Date 2019 Jun 21

PMID 31219227

Citations 8

Authors

Karin Hedenmalm

Kevin Blake

Katherine Donegan

Miguel-Angel Macia

Miguel Gil

Julie Williams

Dolores Montero

Gianmario Candore

Daniel Morales

Xavier Kurz

Peter Arlett

Affiliations

Soon will be listed here.

Abstract

Purpose: In June 2013, following recommendations from the World Health Organization (WHO) and Food and Drug Administration (FDA), the European Medicines Agency agreed updates to the codeine product information regarding use for pain in children younger than 12 years and children undergoing tonsillectomy or adenoidectomy (TA) for obstructive sleep apnoea. This study was conducted to (a) assess effectiveness of these measures on codeine prescribing in the "real-world" setting and (b) test feasibility of a study using a common protocol by regulators with access to databases.

Methods: The study was performed using BIFAP (Spain), CPRD (UK), and IMS® Disease Analyzer (France and Germany) databases. Prescribers included general practitioners (GPs) (France and UK), GPs and paediatricians together (Spain), and GPs, paediatricians, and ear, nose, and throat (ENT) specialists separately (Germany). Between January 2010 and June 2015, prevalence of codeine prescribing was obtained every 6 months, and a time series analysis (joinpoint) was performed. Codeine prescribing within ±30 days of TA was also identified. Furthermore, doses, durations, and prior prescribing of other analgesics were investigated.

Results: Over the 5-year period, codeine prescribing decreased in children younger than 12 years (by 84% in France and Spain, 44% in GP practices in Germany, and 33% in the United Kingdom). The temporal pattern was compatible with the regulatory intervention in France and the United Kingdom, whereas a decrease throughout the study period was seen in Germany and Spain. Decreased prescribing associated with TA was suggested in ENT practices in Germany.

Conclusions: Codeine prescribing for children decreased in line with introduced regulatory measures. Multidatabase studies assessing impact of measures by EU regulators are feasible.

Citing Articles

Addressing Limitations and Future Directions in the Use of Glucocorticoids for Pediatric Nuss Procedure Analgesia: A Critical Appraisal [Letter].

Li Z J Pain Res. 2025; 18:815-816.

PMID: 40008402 PMC: 11853768. DOI: 10.2147/JPR.S522919.

The Challenge of Managing Neuropathic Pain in Children and Adolescents with Cancer.

Coluzzi F, Stefano G, Scerpa M, Rocco M, Di Nardo G, Innocenti A Cancers (Basel). 2025; 17(3).

PMID: 39941827 PMC: 11816330. DOI: 10.3390/cancers17030460.

Commercializing Personal Health Information: A Critical Qualitative Content Analysis of Documents Describing Proprietary Primary Care Databases in Canada.

Spithoff S, Grundy Q Int J Health Policy Manag. 2023; 12:6938.

PMID: 37579404 PMC: 10461871. DOI: 10.34172/ijhpm.2023.6938.

Prescribing Patterns of Codeine and Alternative Medicines in Children in Europe.

Plueschke K, Flynn R, Hedenmalm K, Deli A, Macia-Martinez M, Garcia-Poza P Drug Saf. 2022; 45(10):1069-1081.

PMID: 36001288 PMC: 9492592. DOI: 10.1007/s40264-022-01214-y.

Opioid Analgesic Prescription in French Children: A National Population-Based Study.

Choufi S, Mounier S, Merlin E, Rochette E, Delorme J, Authier N Int J Environ Res Public Health. 2021; 18(24).

PMID: 34948923 PMC: 8702064. DOI: 10.3390/ijerph182413316.

References

Wong C, Lau E, Palozzi L, Campbell F . Pain management in children: Part 1 - Pain assessment tools and a brief review of nonpharmacological and pharmacological treatment options. Can Pharm J (Ott). 2013; 145(5):222-5. PMC: 3567578. DOI: 10.3821/145.5.cpj222. View

Palanisamy A, Bailey C . Codeine in mothers and children: where are we now?. Anaesthesia. 2014; 69(7):655-60. DOI: 10.1111/anae.12716. View

Kim H, Fay M, Feuer E, Midthune D . Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000; 19(3):335-51. DOI: 10.1002/(sici)1097-0258(20000215)19:3<335::aid-sim336>3.0.co;2-z. View

Herrett E, Gallagher A, Bhaskaran K, Forbes H, Mathur R, van Staa T . Data Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 2015; 44(3):827-36. PMC: 4521131. DOI: 10.1093/ije/dyv098. View

Constant I, Ayari Khalfallah S, Brunaud A, Deramoudt V, Fayoux P, Giovanni A . How to replace codeine after tonsillectomy in children under 12 years of age? Guidelines of the French Oto-Rhino-Laryngology--Head and Neck Surgery Society (SFORL). Eur Ann Otorhinolaryngol Head Neck Dis. 2014; 131(4):233-8. DOI: 10.1016/j.anorl.2014.06.001. View

Ingelman-Sundberg M . Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J. 2004; 5(1):6-13. DOI: 10.1038/sj.tpj.6500285. View

Bedson J, Belcher J, Martino O, Ndlovu M, Rathod T, Walters K . The effectiveness of national guidance in changing analgesic prescribing in primary care from 2002 to 2009: an observational database study. Eur J Pain. 2012; 17(3):434-43. PMC: 3592995. DOI: 10.1002/j.1532-2149.2012.00189.x. View

Racoosin J, Roberson D, Pacanowski M, Nielsen D . New evidence about an old drug--risk with codeine after adenotonsillectomy. N Engl J Med. 2013; 368(23):2155-7. DOI: 10.1056/NEJMp1302454. View

Wong C, Lau E, Palozzi L, Campbell F . Pain management in children: Part 2 - A transition from codeine to morphine for moderate to severe pain in children. Can Pharm J (Ott). 2013; 145(6):276-279.e1. PMC: 3567605. DOI: 10.3821/145.6.cpj276. View

10.

Woolf A, Greco C . Why can't we retire codeine?. Pediatrics. 2014; 133(5):e1354-5. DOI: 10.1542/peds.2013-4057. View

11.

Arlett P, Portier G, de Lisa R, Blake K, Wathion N, Dogne J . Proactively managing the risk of marketed drugs: experience with the EMA Pharmacovigilance Risk Assessment Committee. Nat Rev Drug Discov. 2014; 13(5):395-7. DOI: 10.1038/nrd3713-c1. View

12.

Benini F, Barbi E . Doing without codeine: why and what are the alternatives?. Ital J Pediatr. 2014; 40(1):16. PMC: 3996141. DOI: 10.1186/1824-7288-40-16. View

13.

Anderson B . Is it farewell to codeine?. Arch Dis Child. 2013; 98(12):986-8. DOI: 10.1136/archdischild-2013-304974. View

14.

Tremlett M . Wither codeine?. Paediatr Anaesth. 2013; 23(8):677-83. DOI: 10.1111/pan.12190. View

15.

Alm F, Jaensson M, Lundeberg S, Ericsson E . Adherence to Swedish guidelines for pain treatment in relation to pediatric tonsil surgery: A survey of the multidisciplinary team. Int J Pediatr Otorhinolaryngol. 2017; 101:123-131. DOI: 10.1016/j.ijporl.2017.07.040. View

16.

Salvador Rosa A, Moreno Perez J, Sonego D, Garcia Rodriguez L, de Abajo Iglesias F . [The BIFAP project: database for pharmaco-epidemiological research in primary care]. Aten Primaria. 2003; 30(10):655-61. PMC: 7679749. DOI: 10.1016/s0212-6567(02)79129-4. View

17.

Chidambaran V, Sadhasivam S, Mahmoud M . Codeine and opioid metabolism: implications and alternatives for pediatric pain management. Curr Opin Anaesthesiol. 2017; 30(3):349-356. PMC: 5482206. DOI: 10.1097/ACO.0000000000000455. View

18.

Becher H, Kostev K, Schroder-Bernhardi D . Validity and representativeness of the "Disease Analyzer" patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther. 2009; 47(10):617-26. DOI: 10.5414/cpp47617. View

19.

Yellon R, Kenna M, Cladis F, McGhee W, Davis P . What is the best non-codeine postadenotonsillectomy pain management for children?. Laryngoscope. 2014; 124(8):1737-8. DOI: 10.1002/lary.24599. View

20.

Goedecke T, Morales D, Pacurariu A, Kurz X . Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations. Br J Clin Pharmacol. 2017; 84(3):419-433. PMC: 5809349. DOI: 10.1111/bcp.13469. View